Fiscal Year (FY) 2026 Quality Improvement Fund - Improving Access to Dental Services for Children with Neurodevelopmental Disorders (QIF-DNDD)
- Response deadline
- Jul 8, 2026 Closed
- Date posted
- Jun 5, 2026
- Source
- Open notice
Description
The purpose of fiscal year (FY) 2026 Quality Improvement Fund: Improving Access to Dental Services for Children with Neurodevelopmental Disorders (QIF-DNDD) is to increase access to preventive dental and additional dental services and improve dental health outcomes for children with neurodevelopmental disorders (NDDs), including children with autism spectrum and developmental disorders. Through this one-time investment, health centers will build upon existing evidence-based models to pilot innovative approaches to increase access to dental services for children with NDDs, advance the skills and knowledge of your workforce to support access to services, and improve patient outcomes.Applicants for this funding must propose project work plans that include:Specific evidence-based models and innovative approaches that will increase access to dental services and improve patient outcomes for children with NDDs.Plans to advance the skills and knowledge of the health center workforce to support access to dental services for children with NDDs.
Classifications
- NAICS93.224
Documents (4)
Contacts
Similar contracts
- Fiscal Year 2027 Expanding Nutrition ServicesDue Sep 9, 2026
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not AllowedDue Apr 1, 2027
- Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)Due Jul 14, 2026
- Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)Due Mar 1, 2028